Autoplasma as a Hemostatic Agent for Endoscopic Surgery of Hollow Organs

Introduction. To maximize the effectiveness of hemostatic technologies, it is necessary to optimize local hemostasis through hybrid and controlled approaches, as well as to improve the conditions for tissue surgical dissection preventing perforation of hollow organs. This study is aimed at assessing the efficacy of stopping bleeding and the safety of resection of digestive hollow organs in experimental models of trauma to abdominal organs in laboratory animals.

Materials and methods. Experiments were carried out in vivo on 20 rabbits. All animals were divided into 4 experimental groups (5 animals each): I — the control group, in which no methods for stopping bleeding were used; II — the group, in which infiltration of the wall of a hollow organ with saline solution was used; III — the group, in which physical hemostasis was applied using an electrosurgical unit and an argon plasma coagulation apparatus; IV — the group, animals in which underwent controlled local biological hemostasis using autoplasma. Prior to laparotomy, 2–3 ml of whole blood was taken from the rabbit’s ear for preliminary preparation of autoplasma. The prepared autoplasma was introduced into the area of resection or other operation of the mucous membrane of the rabbit’s digestive tract.

Results and discussion. Although no statistical difference in the time of stopping bleeding was observed between the control (I) and saline (II) groups, one more episode of bleeding was noted in group II. Preventive local administration of autoplasma (group IV) was established to have a high hemostatic potential. As expected, electrocoagulation was more effective than saline; however, hemostasis achieved by means of argon plasma coagulation is characterized by rapid formation of a necrotic zone, which may lead to undesirable consequences in the long-term period.

Conclusion. Preventive local administration of autoplasma and recombinant human protein has a high hemostatic potential in animals. In comparison, electrocoagulation is less effective due to the rapid filling of the pathological focus with blood. 

1. Alali A., Espino A., Moris M., Martel M., Schwartz I., Cirocco M., et al. Endoscopic resection of ampullary tumours: long-term outcomes and adverse events. J Can Assoc Gastroenterol. 2020;3(1):17–25. DOI: 10.1093/jcag/gwz007

2. Achkasov E.E., Ulyanov A.A., An V.K., Bezuglov E.N. The use of autoplasma rich in platelet growth factors (APRPGF) on results of treatment of patients with pilonidal sinus abscess. Khirurgiia. 2013;(12):43–7 (In Russ.).

3. Bochkova T.V., Gantsev S.Kh. Experimental substantiation of autoplasma application as a haemostatic agent in endoscopic operations in the digestive tract. Serbian Journal of Experimental and Clinical Research. Epub 2020. DOI: 10.2478/sjecr-2020-0033

4. Guidelines for conducting preclinical trials of drugs. Moscow: Grif i K.; 2012. Pt. 1. 944 p. (In Russ.).

5. Wang T.X., Zhang J., Cui L.H., Tian J.J., Wei R. Efficacy of therapeutic endoscopy for gastrointestinal lesion (GI): a network meta-analysis. Pak J Med Sci. 2019;35(2):561–8. DOI: 10.12669/pjms.35.2.636

6. Rajala M.W., Ginsberg G.G. Tips and tricks on how to optimally manage patients with upper gastrointestinal bleeding. Gastrointest Endosc Clin N Am. 2015;25(3):607–17. DOI: 10.1016/j.giec.2015.02.004

7. Parsi M.A., Trindate A.J., Bhutani M.S. Cryotherapy in gastrointestinal endoscopy. VideoGIE. 2017;2(5):89–95. DOI: 10.1016/j. vgie.2017.01.021

8. Zabelin M.V., Safonov A.S. Obstructive resection and colostomy from short-scar incision in acute colonic obstruction of tumoral genesis. Healthcare, education and security. 2017;(4):22–8 (In Russ.).

9. Fujii-Lau L.L., Wong Kee Song L.M., Levy M.J. New technologies and approaches to endoscopic control of gastrointestinal bleeding. Gastrointest Endosc Clin N Am. 2015;25(3):553–67. DOI: 10.1016/j.giec.2015.02.005

10. Murashko D.A., Semenov M.S., Ilyin M.A., Osipov A.N., Samoilov A.S., Zabelin M.V. The prospects of the sampling live tumoral material of patients with aggressive tumor diseases. Healthcare, education and security. 2017;1:7–17 (In Russ.).

11. Ghassemi K.A., Jensen D.M. Evolving techniques for gastrointestinal endoscopic hemostasis treatment. Expert Rev Gastroenterol Hepatol. 2016;10(5):615–23. DOI: 10.1586/17474124.2016.1130623

12. Prei J.C., Barmeyer C., Bürgel N., Daum S., Epple H.J., Günther U., et al. EndoClot polysaccharide hemostatic system in nonvariceal gastrointestinal bleeding: results of a prospective multicentre observational pilot study. J Clin Gastroenterol. 2016;50(10):e95–e100. DOI: 10.1097/MCG.0000000000000615

13. García de la Filia I., Hernanz N., Vázquez Sequeiros E., Tavío Hernández E. Recurrent gastrointestinal bleeding secondary to Dieulafoy’s lesion successfully treated with endoscopic ultrasound-guided sclerosis. Gastroenterol Hepatol. 2018;41(5):319–20. DOI: 10.1016/j.gastrohep.2017.06.002

14. Urakov A., Urakova N., Reshetnikov A., Kopylov M., Chernova L. Solvents of pus-medicines with physical-chemical aggressive action. J Phys Conf Ser. 2017;790:012033. DOI: 10.1088/1742-6596/790/1/012033

15. Goldberg Ye.D., Dygai A.M., Zhdanov V.V., Zyuz’kov G.N., Miroshnichenko L.A., Simanina E.V., et al. Pharmacology aspects of regenerative medicine. Bulletin of Experimental Biology and Medicine. 2008;(S2):14–20 (In Russ.).

16. Nabi Z. Complications of therapeutic gastroscopy/colonoscopy other than resection. Best Pract Res Clin Gastroenterol. 2016;30(5):719–33. DOI: 10.1016/j.bpg.2016.10.010

17. Gurevich K.G., Urakov A.L., Bashirova L.I., Samorodov A.V., Purygin P.P., Ermokhin V.A., et al. The hemostatic activity of bis (2-aminoethan-1-sulfonate) calcium. Asian J Pharmaceut Clin Res. 2018;11(11):452–5. DOI: 10.22159/ajpcr.2018.v11i11.29049

18. Kasatkin A.A., Urakov A.A., Lukoyanov I.A. Nonsteroidal anti-inflammatory drugs causing local inflammation of tissue at the site of injection. J Pharmacol Pharmacother. 2016;7(1):26–8. DOI: 10.4103/0976-500X.179359

19. Gomzikova M.O., Gaifullina R.F., Mustafin I.G., Chernov V.M., Miftahova Z.R., Galyavich AS., et al. Membrane microvesicles: biological properties and involvement in pathogenesis of diseases. Cell Transplantology and Tissue Engineering. 2013;8(1):6–11 (In Russ.).